Pain News and Research

Latest Pain News and Research

New paper analytical devices can screen fake antimalarial drugs

On Wednesday, 5/29/13, the Wall Street Journal published an article titled "Africa's Malaria Battle: Fake Drug Pipeline Undercuts Progress." The piece outlines a counterfeit pharmaceutical problem that is top of mind at Saint Mary's College in Notre Dame, IN. Chemistry Professor Toni Barstis and her undergraduate students at this Catholic, women's, liberal arts college have researched and developed Paper Analytical Devices (PADs) that can screen whether an antimalarial drug is real.

1 Jun 2013

Mayo Clinic research shows that revascularization has reduced need for amputations by 40%

Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.

1 Jun 2013

Depomed receives complete response letter for SEFELSA NDA

Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.

1 Jun 2013

Gulf Coast Spine Care offers effective treatment options for sciatica

Finding relief from sciatica is imperative, and Gulf Coast Spine Care offers proven, effective treatment options for these individuals. Recently, the medical center has started offering additional treatment options for the benefit of its patients who suffer from this condition, and these treatments have provided patients with considerable improvement to their quality of life.

1 Jun 2013

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

A new study conducted in an ethnically diverse and predominantly low income population found that only one-fifth of rheumatoid arthritis patients had an overall adherence rate to prescribed oral medications at 80% or greater.

1 Jun 2013

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Exelixis, Inc. today announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal cell carcinoma who have experienced disease progression following treatment with at least one prior VEGFR tyrosine kinase inhibitor.

31 May 2013

Johns Hopkins gynecologic surgeons perform robotic hysterectomy using single, small incision

Two Johns Hopkins gynecologic surgeons are among the first in the nation to perform a robotic hysterectomy using a single, small incision.

31 May 2013

Comprehensive analyses of the benefits and risks of NSAIDs

Charles H. Hennekens, MD, DrPH, the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University has published in the current issue of The Lancet the most comprehensive analyses of the benefits and risks of non-steroidal anti-inflammatory drugs, which include cyclo-oxygenase-2 inhibitors (coxibs).

31 May 2013

Three easy steps for cancer survivorship

Incorporating just three easy steps into a daily routine can increase a cancer patient's chance at survival, according to a physician who specializes in cancer survivorship.

31 May 2013

Taking precautions to protect health during summer

Summer is a time for enjoying warm weather, but spending time outside also increases the risk of contracting serious conditions like Lyme disease, poison ivy rashes, West Nile virus and allergic reactions to bee stings.

31 May 2013

Extremely low doses of THC protect the brain from long-term cognitive damage

Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms.

31 May 2013

Innovative approach helps Virginia mount effective response to contaminated steroid crisis

An innovative "hybrid" surveillance strategy-highlighted by close cooperation between public health officials and clinical partners-helped Virginia mount an efficient and effective response to the ongoing outbreak of fungal meningitis and other infections, according to a report in the July/August issue of Journal of Public Health Management and Practice.

31 May 2013

Queen's University Belfast scientists awarded research grants to tackle tropical diseases

Queen's University Belfast has been announced as a Grand Challenges Explorations winner, an initiative founded by the Bill & Melinda Gates Foundation. Scientists at the University's Institute for Global Food Security have been awarded grants to pursue two Innovative global health and development research projects aimed at tackling tropical diseases.

31 May 2013

CREON Delayed-Release Capsules now available in US for patients with EPI

AbbVie announced that a new, higher-dose capsule of CREON (pancrelipase) Delayed-Release Capsules is commercially available in the United States. The U.S. Food and Drug Administration recently approved CREON in a 36,000 lipase-unit dose to treat patients with exocrine pancreatic insufficiency due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions.

31 May 2013

FDA issues complete response letter to Endo's NDA for AVEED injection

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.

31 May 2013

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.

31 May 2013

Whiplash therapy: an interview with Dr Williamson and Dr Williams, University of Warwick

A whiplash injury is a common soft-tissue injury that may result in neck pain and other symptoms like headaches and arm pain.

30 May 2013

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Pacira Pharmaceuticals reports results of EXPAREL Phase 2/3 clinical trial for TKA

Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.

29 May 2013

UCLA researchers show that bacteria ingested in food can affect brain function

UCLA researchers now have the first evidence that bacteria ingested in food can affect brain function in humans. In an early proof-of-concept study of healthy women, they found that women who regularly consumed beneficial bacteria known as probiotics through yogurt showed altered brain function, both while in a resting state and in response to an emotion-recognition task.

29 May 2013

Pain News and Research

Latest Pain News and Research

New paper analytical devices can screen fake antimalarial drugs

Mayo Clinic research shows that revascularization has reduced need for amputations by 40%

Depomed receives complete response letter for SEFELSA NDA

Gulf Coast Spine Care offers effective treatment options for sciatica

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Johns Hopkins gynecologic surgeons perform robotic hysterectomy using single, small incision

Comprehensive analyses of the benefits and risks of NSAIDs

Three easy steps for cancer survivorship

Taking precautions to protect health during summer

Extremely low doses of THC protect the brain from long-term cognitive damage

Innovative approach helps Virginia mount effective response to contaminated steroid crisis

Queen's University Belfast scientists awarded research grants to tackle tropical diseases

CREON Delayed-Release Capsules now available in US for patients with EPI

FDA issues complete response letter to Endo's NDA for AVEED injection

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

Whiplash therapy: an interview with Dr Williamson and Dr Williams, University of Warwick

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Pacira Pharmaceuticals reports results of EXPAREL Phase 2/3 clinical trial for TKA

UCLA researchers show that bacteria ingested in food can affect brain function

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in